Advisory committees on medicines & chemicals scheduling (ACMS & ACCS)
Advisory Committee on Medicines Scheduling (ACMS) & Advisory Committee on Chemicals Scheduling (ACCS)
16 January 2013
Role of the ACMS and the ACCS
Scheduling is a classification system that controls how medicines and chemicals are accessible to consumers. Medicines and chemicals are grouped into Schedules according to the appropriate level of regulatory control over their availability (e.g. Schedule 4 - medicines available only by prescription; Schedule 2 - medicines available over the counter in pharmacies).
Under revised scheduling arrangements, which took effect on 1 July 2010, the Secretary to the Department of Health and Ageing (DoHA) (or the Secretary's delegate) superseded the National Drugs and Poisons Schedule Committee (NDPSC) as the decision maker for the scheduling of medicines and chemicals. The revised arrangements also established two expert advisory committees, the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS), as statutory committees under the Therapeutic Goods Act 1989 (the Act) to advise and make recommendations to the Secretary of the DoHA (or delegate) on the level of access required for medicines and chemicals.
Committee membership
Under the Therapeutic Goods Regulations 1990 (the Regulations), each Committee comprises of nine nominated members and no more than six appointed members.
Under the Act, the Commonwealth, each State, the Australian Capital Territory and the Northern Territory are entitled to nominate a member on each of these Committees. These Committee members are referred to as 'nominated' members.
Under the Regulations, the Minister must appoint no more than six additional members, selected through an open invitation process.
These Committee members are referred to as 'appointed' members. In accordance with the Regulations, all Committee members are required to have expertise in at least one of the following fields:
ACMS
- the regulation of scheduled medicines in Australia
- toxicology or pharmacology
- clinical pharmacology
- pharmacy medicine
- medical practice
- consumer health issues relating to the regulation of therapeutic goods
- industry issues relating to the regulation of therapeutic goods
ACCS
- the regulation of scheduled chemicals in Australia
- veterinary medicines or veterinary pathology
- toxicology
- industrial or domestic chemicals
- agricultural or veterinary chemicals
- clinical aspects of human poisoning
- occupational health issues, particularly as a medical practitioner
- consumer health issues relating to the regulation of chemicals
- industry issues relating to the regulation of chemicals
Committee members
Advisory Committee on Medicines Scheduling (ACMS) members
Chair
- Mr John Jackson, BPharm, GDHP, MPH, FSHP
Appointed members
- Prof Andrew H Dawson
- Mrs Mary Emanuel, BPharm, MPS
- A/Prof John Gullotta, AM
- Mr John Daye, OAM
- Mr David Newgreen
Nominated members
- Dr Peter Bird
Commonwealth - Mr Peter Gilfedder
New South Wales - Ms Megan Smith
Victoria - Dr Susan Ballantyne
Queensland - Ms Jane Carpenter
Western Australia - Ms Elizabeth Hender
South Australia - Mr James Galloway
Tasmania - Ms Gay Lavery
Northern Territory - Ms Vivien Bevan
ACT
Advisory Committee on Chemicals Scheduling (ACCS) members
Chair
- Mr Peter Di Marco, BSc, PhD, FATS
Appointed members
- Ms Bronwyn Capanna
- Prof Andrew H Dawson
- Dr Simon Robinson, BSc, BVetMed, MBA, MRCVS
- Em Prof Alan A Seawright
- A/Prof John Edwards
Nominated members
- Mr Paul Harvey
Commonwealth - Mr Peter Gilfedder
New South Wales - Ms Megan Smith
Victoria - Dr Gerard Neville
Queensland - Ms Jane Carpenter
Western Australia - Dr David Simon
South Australia - Mr James Galloway
Tasmania - Ms Gay Lavery
Northern Territory - Ms Vivien Bevan
ACT
ACMS and ACCS meeting dates & decisions timeframes
It is anticipated that the ACMS and ACCS will hold three face to face meetings annually. However, this will ultimately be determined by the individual and/or joint meeting agendas of proposals referred to the Committees by the delegate.
Stakeholders should note that the following timetable outlines the anticipated administrative timeframes associated with matters referred by the delegates to an expert advisory committee meeting. This timetable also reflects public consultation timeframes as required by legislation.
| February 2012 | June 2012 | October 2012 | March 2013 | July 2013 | November 2013 | |
|---|---|---|---|---|---|---|
| General scheduling applications1 | ||||||
| Lodgement deadline2 for scheduling applications | 4 Oct 2011 | 14 Feb 2012 | 5 Jun 2012 | 23 Oct 2012 | 19 Mar 2013 | 23 Jul 2013 |
| Public Notice3 pre-meeting submissions. Inviting public comment on proposals referred to the Committees by the scheduling delegate |
14 Dec 2011 | 26 Apr 2012 | 14 Aug 2012 | 29 Nov 2012 | 24 Apr 2013 | 29 Aug 2013 |
| Public comment due | 19 Jan 2012 | 25 May 2012 | 12 Sep 2012 | 17 Jan 2013 | 23 May 2013 | 26 Sep 2013 |
| Agvet and delegate-initiated scheduling applications4 | ||||||
| Lodgement deadline5 for agvet scheduling applications | n/a | n/a | n/a | 14 Dec 2012 | 9 May 2013 | 12 Sep 2013 |
| Public Notice6 pre-meeting submissions. Inviting public comment on proposals referred to the Committees by the scheduling delegate |
n/a | n/a | n/a | 7 Feb 2013 | 13 Jun 2013 | 17 Oct 2013 |
| Public comment due | n/a | n/a | n/a | 7 Mar 2013 | 11 Jul 2013 | 14 Nov2013 |
| 2012-2013 ACCS and ACMS meeting dates | ||||||
| ACCS meeting | 21 Feb 2012 | 27 Jun 2012 | 24 Oct 2012 | 19 Mar 2013 | 23 Jul 2013 | 26 Nov 2013 |
| ACMS-ACCS joint meeting | nil | 27 Jun 2012 | 24 Oct 2012 | 20 Mar 2013 (if applicable) |
24 Jul 2013 (if applicable) |
27 Nov 2013 (if applicable) |
| ACMS meeting | 22 Feb 2012 | 27 Jun 2012 | 24 & 25 Oct 2012 | 20 or 21 Mar 2013 | 24 or 25 Jul 2013 | 27 or 28 Nov 2013 |
| Anticipated timetable for delegate's decision-making following ACMS/ACCS consideration | ||||||
| Public Notice of delegate's interim decision7 Inviting further public comment |
26 Apr 2012 | 5 Sep 2012 | 19 Dec 2012 | 23 May 2013 | 26 Sep2013 | 20 Feb 2014 |
| Public comment due | 10 May 2012 | 19 Sep 2012 | 11 Jan 2013 | 6 June 2013 | 14 Oct 2013 | 6 Mar 2014 |
| Public Notice of delegate's final decision | 30 May 2012 | 10 Oct 2012 | 6 Feb 2013 | 27 June 2013 | 31 Oct 2013 | 27 Mar 2014 |
| Anticipated that the delegate's final decisions following ACMS/ACCS consideration could be included in the following SUSMP Amendments, unless otherwise decided by the delegate (likely to occur frequently) | ||||||
| SUSMP Amendment and effective date | SUSMP No.3 Amendments No. 1&2 1 Sep 2012 |
SUSMP No.3 Amendment No. 3 1 Jan 2013 |
SUSMP No.3 Amendment No.4 1 May 2013 |
SUSMP No.4 Amendment No.1 1 Sep 2013 |
SUSMP No.4 Amendment No.2 1 Jan 2014 |
SUSMP No.4 Amendment No.3 1 May 2014 |
- General scheduling applications
General scheduling applications are those applications proposing to amend the Poisons Standard and must be supported by sufficient information and be in a form approved by the Secretary. - Lodgement deadline
Each applicant is required to lodge an application for consideration by a Scheduling Delegate 18 weeks before an advisory committee meeting. Not all applications are referred to a committee meeting; in some instances the delegate may make a delegate-only decision. - Public Notice - pre-meeting submissions
The Public Notice provides the opportunity for public comment on the scheduling proposals that have been referred to the advisory committees for advice. The Public Notice is open for consultation on the TGA website for a period of 20 business days - Agvet and delegate-initiated Scheduling Applications
Applications related to agricultural and veterinary chemicals (agvet) must be referred by the Australian Pesticides and Veterinary Medicines Authority (APVMA).
Delegate-initiated applications are those that the delegate themselves have referred to the advisory committees for advice. - Lodgement deadline
Agvet applications are required to be lodged for consideration by a Scheduling Delegate 7 weeks before an advisory committee meeting. Not all applications are referred to a committee meeting; in some instances the delegate may make a delegate-only decision.
There is no lodgement deadline for delegate-initiated applications. - Public Notice - pre-meeting submissions
The Public Notice provides the opportunity for public comment on the scheduling proposals that have been referred to the advisory committees for advice. The Public Notice is open for consultation on the TGA website for a period of 20 business days. - Public Notice - delegate's interim decision
Persons who provide comment at the Public Notice-pre-meeting submission stages3,6 are then also invited to comment on the delegate's interim decision and have 10 business days to respond.
Scheduling secretariat
Secretariat services are provided by the DoHA Office of Chemical Safety and Environmental Health. The contact details for the Secretariat are:
| smp@health.gov.au | |
| Phone | +61 2 6289 2659 |
| Fax | +61 2 6289 2650 |
| Postal address | The Secretary Medicines and Poisons Scheduling Secretariat Office of Chemical Safety (MDP 88) Department of Health and Ageing GPO Box 9848 Canberra ACT 2600 Australia |
| Street address (for deliveries) |
Department of Health and Ageing Level 5, Scarborough House Atlantic Street Woden ACT 2606 Australia |
Content last updated: Wednesday, 16 January 2013
Content last reviewed: Wednesday, 16 January 2013
Web page last updated: Wednesday, 16 January 2013
URL: http://www.tga.gov.au/about/committees-acmcs.htm
